Lehman-McKeeman L D, Andrews G K, Klaassen C D
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66103.
Biochem J. 1988 Jan 15;249(2):429-33. doi: 10.1042/bj2490429.
Induction of metallothionein-I (MT-I) and metallothionein-II (MT-II) by glucocorticoids was determined by h.p.l.c. analysis of proteins and Northern-blot analysis of MT mRNAs. Rats were injected with dexamethasone (0.03-10 mumol/kg) and hepatic concentrations of MTs were determined 24 h later. In control rats, only MT-II was detected (9.4 +/- 2.5 micrograms/g of liver), whereas the hepatic concentration of MT-I was below the detection limit (5 micrograms of MT/g). Dexamethasone did not increase MT-I above the detection limit at any dosage tested, but MT-II increased to 2.5 times control values at dosages of 0.30 mumol/kg and higher. Time-course experiments indicated that MT-II reached a maximum at 24 h after a single dosage of dexamethasone and returned to control values by 48 h. To determine whether dexamethasone increased MT-I in liver, samples were saturated with 109Cd, after which the amount of 109Cd in MT-I and MT-II was determined. Results indicated that, by this approach, MT-I and MT-II could be detected in control rats, and there was approx. 1.8 times more 109Cd in MT-II than in MT-I. At 24 h after administration of dexamethasone (1 mumol/kg), there was a small increase in the amount of 109Cd bound to MT-I, whereas the amount of 109Cd bound to MT-II increased to more than 2 times control values. Northern-blot hybridization with mouse cRNA probes indicated that MT-I and MT-II mRNAs increased co-ordinately after administration of dexamethasone. Thus, although glucocorticoids increase both MT-I and MT-II mRNAs, MT-II preferentially accumulates after administration of dexamethasone.
通过蛋白质的高效液相色谱分析和金属硫蛋白(MT)mRNA的Northern印迹分析,测定糖皮质激素对金属硫蛋白-I(MT-I)和金属硫蛋白-II(MT-II)的诱导作用。给大鼠注射地塞米松(0.03 - 10 μmol/kg),24小时后测定肝脏中MT的浓度。在对照大鼠中,仅检测到MT-II(9.4±2.5微克/克肝脏),而MT-I的肝脏浓度低于检测限(5微克MT/克)。在所测试的任何剂量下,地塞米松都未使MT-I增加到检测限以上,但在剂量为0.30 μmol/kg及更高时,MT-II增加到对照值的2.5倍。时间进程实验表明,单次给予地塞米松后,MT-II在24小时达到最大值,并在48小时恢复到对照值。为了确定地塞米松是否增加肝脏中的MT-I,将样品用109Cd饱和,然后测定MT-I和MT-II中109Cd的含量。结果表明,通过这种方法,可以在对照大鼠中检测到MT-I和MT-II,并且MT-II中的109Cd比MT-I中的大约多1.8倍。在给予地塞米松(1 μmol/kg)24小时后,与MT-I结合的109Cd量略有增加,而与MT-II结合的109Cd量增加到对照值的2倍以上。用小鼠cRNA探针进行的Northern印迹杂交表明,给予地塞米松后MT-I和MT-II的mRNA协同增加。因此,尽管糖皮质激素增加了MT-I和MT-II的mRNA,但地塞米松给药后MT-II优先积累。